Vitamin D receptor and Jak-STAT signaling crosstalk results in calcitriol-mediated increase of hepatocellular response to IFN-α

Journal of Immunology

Volumn 192, Issue 12, 2014, Pages 6037-6044

  Lange, Christian M ^a,b   Gouttenoire, Jérôme ^a   Duong, François H T ^c   Morikawa, Kenichi ^a,d   Heim, Markus H ^c   Moradpour, Darius ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CALCITRIOL; JANUS KINASE; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; VITAMIN D RECEPTOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; LIFE CYCLE STAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPLICON; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

CALCITRIOL; CELL LINE; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; JANUS KINASES; PHOSPHORYLATION; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; VIRUS REPLICATION; VITAMINS;

EID: 84902145665     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302296     Document Type: Article

References (30)

1. Brody, H. 2011. Hepatitis C. Nature 474:S1-S21.
2. Scheel, T. K., and C. M. Rice. 2013. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat. Med. 19:837-849.
3. Lange, C. M., I. M. Jacobson, C. M. Rice, and S. Zeuzem. 2014. Emerging therapies for the treatment of hepatitis C. EMBO Mol. Med. 6:4-15.
4. Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773.
5. Von Essen, M. R., M. Kongsbak, P. Schjerling, K. Olgaard, N. Odum, and C. Geisler. 2010. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat. Immunol. 11:344-349.
6. Lange, C. M., J. Bojunga, E. Ramos-Lopez, M. Von Wagner, A. Hassler, J. Vermehren, E. Herrmann, K. Badenhoop, S. Zeuzem, and C. Sarrazin. 2011. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J. Hepatol. 54:887-893.
7. Petta, S., C. Cammà, C. Scazzone, C. Tripodo, V. Di Marco, A. Bono, D. Cabibi, G. Licata, R. Porcasi, G. Marchesini, and A. Craxí. 2010. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 51:1158-1167.
8. Lange, C. M., S. Bibert, Z. Kutalik, P. Burgisser, A. Cerny, J. F. Dufour, A. Geier, T. J. Gerlach, M. H. Heim, R. Malinverni, et al; Swiss Hepatitis C Cohort Study Group. 2012. A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PLoS ONE 7:e40159.
9. Abu-Mouch, S., Z. Fireman, J. Jarchovsky, A. R. Zeina, and N. Assy. 2011. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients. World J. Gastroenterol. 17:5184-5190.
10. Gal-Tanamy, M., L. Bachmetov, A. Ravid, R. Koren, A. Erman, R. Tur-Kaspa, and R. Zemel. 2011. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 54:1570-1579.
11. 3 suppresses hepatitis C virus production. Hepatology 56:1231-1239.
12. Blight, K. J., A. A. Kolykhalov, and C. M. Rice. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290:1972-1974.
13. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Kräusslich, M. Mizokami, et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
14. Pietschmann, T., A. Kaul, G. Koutsoudakis, A. Shavinskaya, S. Kallis, E. Steinmann, K. Abid, F. Negro, M. Dreux, F. L. Cosset, and R. Bartenschlager. 2006. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. USA 103:7408-7413.
15. Lindenbach, B. D., M. J. Evans, A. J. Syder, B. Wölk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, R. O. Hynes, D. R. Burton, J. A. McKeating, and C. M. Rice. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626.
16. Morikawa, K., J. Gouttenoire, C. Hernandez, V. L. Dao Thi, H. T. Tran, C. M. Lange, M. T. Dill, M. H. Heim, O. Donzé, F. Penin, et al. 2014. Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A protease. Hepatology 59:423-433.
17. Bellecave, P., M. Sarasin-Filipowicz, O. Donzé, A. Kennel, J. Gouttenoire, E. Meylan, L. Terracciano, J. Tschopp, C. Sarrazin, T. Berg, et al. 2010. Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system. Hepatology 51:1127-1136.
18. Dill, M. T., F. H. Duong, J. E. Vogt, S. Bibert, P. Y. Bochud, L. Terracciano, A. Papassotiropoulos, V. Roth, and M. H. Heim. 2011. Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. Gastroenterology 140:1021-1031.
19. Moradpour, D., P. Kary, C. M. Rice, and H. E. Blum. 1998. Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology 28:192-201.
20. Sarasin-Filipowicz, M., X. Wang, M. Yan, F. H. Duong, V. Poli, D. J. Hilton, D. E. Zhang, and M. H. Heim. 2009. Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43. Mol. Cell. Biol. 29:4841-4851.
21. Rosen, C. J. 2011. Clinical practice. Vitamin D insufficiency. N. Engl. J. Med. 364:248-254.
22. Campbell, F. C., H. Xu, M. El-Tanani, P. Crowe, and V. Bingham. 2010. The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochem. Pharmacol. 79:1-9.
23. Schindler, C., D. E. Levy, and T. Decker. 2007. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282:20059-20063.
24. Schindler, C., K. Shuai, V. R. Prezioso, and J. E. Darnell, Jr. 1992. Interferondependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257:809-813.
25. Schoggins, J. W., S. J. Wilson, M. Panis, M. Y. Murphy, C. T. Jones, P. Bieniasz, and C. M. Rice. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485.
26. Uddin, S., F. Lekmine, N. Sharma, B. Majchrzak, I. Mayer, P. R. Young, G. M. Bokoch, E. N. Fish, and L. C. Platanias. 2000. The Rac1/p38 mitogenactivated protein kinase pathway is required for interferon a-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J. Biol. Chem. 275:27634-27640.
27. Stöcklin, E., M. Wissler, F. Gouilleux, and B. Groner. 1996. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726-728.
28. 3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signaling via the Janus kinase (JAK2)/signal transducers and activators of transcription (STAT5) system in osteoblast-like cells. J. Biol. Chem. 277:34879-34884.
29. Vidal, M., C. V. Ramana, and A. S. Dusso. 2002. Stat1-vitamin D receptor interactions antagonize 1, 25-dihydroxyvitamin D transcriptional activity and enhance Stat1-mediated transcription. Mol. Cell. Biol. 22:2777-2787.
30. 3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 377:242-250